Cutler Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-800
Closed -$1K 4275
2023
Q1
$1K Buy
+800
New +$33.6K ﹤0.01% 3612
2022
Q4
Sell
-1,100
Closed -$2K 5362
2022
Q3
$2K Sell
1,100
-300
-21% -$12.8K ﹤0.01% 4338
2022
Q2
$3K Sell
1,400
-500
-26% -$21K ﹤0.01% 4140
2022
Q1
$4K Sell
1,900
-800
-30% -$35.2K ﹤0.01% 4350
2021
Q4
$4K Buy
2,700
+900
+50% +$42.6K ﹤0.01% 4410
2021
Q3
$1K Hold
1,800
﹤0.01% 5490
2021
Q2
$2K Hold
1,800
﹤0.01% 5112
2021
Q1
$3K Sell
1,800
-400
-18% -$21.3K ﹤0.01% 4785
2020
Q4
$11K Buy
2,200
+500
+29% +$23.9K ﹤0.01% 3153
2020
Q3
$3K Sell
1,700
-3,200
-65% -$140K ﹤0.01% 3932
2020
Q2
$4K Sell
4,900
-4,200
-46% -$174K ﹤0.01% 3519
2020
Q1
$5K Buy
9,100
+700
+8% +$29.8K ﹤0.01% 3117
2019
Q4
$40K Buy
8,400
+5,300
+171% +$210K ﹤0.01% 1784
2019
Q3
$1K Buy
3,100
+200
+7% +$7.43K ﹤0.01% 3877
2019
Q2
$7K Buy
+2,900
New +$114K ﹤0.01% 2939
2017
Q2
Sell
-19,400
Closed -$11K 7203
2017
Q1
$11K Buy
19,400
+16,400
+547% +$668K ﹤0.01% 3968
2016
Q4
$1K Sell
3,000
-23,200
-89% -$944K ﹤0.01% 6198
2016
Q3
$21K Buy
26,200
+21,400
+446% +$972K ﹤0.01% 3389
2016
Q2
$4K Buy
+4,800
New +$203K ﹤0.01% 5213
2016
Q1
Sell
-3,700
Closed -$3K 7325
2015
Q4
$3K Buy
+3,700
New +$189K ﹤0.01% 5404

Other funds holding XPH

Cutler Group's XPH Position: Q3 2023 in Review

Cutler Group sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2023, closing a stake of 330 shares — an estimated $13K sold.

Cutler Group first reported a position in XPH in Q1 2016 and held it in 26 quarters. The position peaked at $269K in Q3 2016. 65 funds tracked by Wall St. Rank hold XPH as of Q3 2023.

  • Cutler Group reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 330 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2023, an estimated $13K.
  • Cutler Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2016 and held it in 26 quarters.
  • Cutler Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $269K in Q3 2016.
  • 65 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.